semaglutide and cagrilintide VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity Type 2 Diabetes Semaglutide and cagrilintide have each

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

This JAMA Internal Medicine patient page covers #GLP1 weight-loss medications, focusing on food craving reduction, blood glucose control, dietary strategies, exercise for muscle retention, and lifestyle changes to prevent weight regain.

The role of SU in diabetes management is explicit, and the present consensus aims to emphasize the benefits and reposition SU in India

GIP enhances calorie burning and insulin response

More common in young women (2040 yrs), higher prevalence in colder climates

Katren S